scholarly article | Q13442814 |
P2093 | author name string | Yong Zhou | |
Zhenyu You | |||
Shaoqing Chen | |||
Yuling Guo | |||
Xiaolang Wang | |||
Wenyan Chen | |||
P2860 | cites work | Retracted: TNF-α Induces Cytosolic Phospholipase A2 Expression in Human Lung Epithelial Cells via JNK1/2- and p38 MAPK-Dependent AP-1 Activation | Q34998514 |
Reduced levels of ATF-2 predispose mice to mammary tumors. | Q35676210 | ||
ATF2 - at the crossroad of nuclear and cytosolic functions | Q36211955 | ||
ATF2 on the double - activating transcription factor and DNA damage response protein | Q36970655 | ||
The ROS/JNK/ATF2 pathway mediates selenite-induced leukemia NB4 cell cycle arrest and apoptosis in vitro and in vivo | Q37424067 | ||
Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up | Q37489156 | ||
Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells | Q38508200 | ||
Helicobacter pylori enhances CIP2A expression and cell proliferation via JNK2/ATF2 signaling in human gastric cancer cells | Q39036716 | ||
Expression and prognostic value of activating transcription factor 2 (ATF2) and its phosphorylated form in mammary carcinomas. | Q39866724 | ||
Activating transcription factor-2 in survival mechanisms in head and neck carcinoma cells | Q42763314 | ||
The biotinylation of the rabbit serotonin antibody and its application to immunohistochemical studies using the two-step ABC method. | Q45171456 | ||
Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival. | Q47316164 | ||
A switch from canonical to noncanonical Wnt signaling mediates early differentiation of human neural stem cells. | Q54332448 | ||
Global cancer statistics | Q22241238 | ||
PKCε promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria | Q24304390 | ||
Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic review | Q27022535 | ||
Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression | Q30432236 | ||
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data | Q33546241 | ||
Adjuvant or neoadjuvant chemotherapy for NSCLC. | Q33658228 | ||
A role for ATF2 in regulating MITF and melanoma development | Q33784589 | ||
Emerging roles of ATF2 and the dynamic AP1 network in cancer | Q33866973 | ||
Lung cancer: progress in diagnosis, staging and therapy. | Q34101836 | ||
Epithelioid sarcoma: new insights based on an extended immunohistochemical analysis | Q34226269 | ||
Inhibition of melanoma growth by small molecules that promote the mitochondrial localization of ATF2 | Q34669835 | ||
An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis | Q34796148 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 760-766 | |
P577 | publication date | 2015-11-16 | |
P1433 | published in | Oncology Letters | Q20640514 |
P1476 | title | Activating transcription factor 2 expression mediates cell proliferation and is associated with poor prognosis in human non-small cell lung carcinoma | |
P478 | volume | 11 |
Q89514232 | 6'-O-galloylpaeoniflorin regulates proliferation and metastasis of non-small cell lung cancer through AMPK/miR-299-5p/ATF2 axis |
Q64927969 | ATF2 partly mediated the expressions of proliferative factors and inhibited pro-inflammatory factors' secretion in arsenite-treated human uroepithelial cells. |
Q37064522 | ATF2 predicts poor prognosis and promotes malignant phenotypes in renal cell carcinoma |
Q55007013 | Downregulation of histone demethylase JMJD1C inhibits colorectal cancer metastasis through targeting ATF2. |
Q55618243 | SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression. |
Q52716813 | Silencing activating transcription factor 2 promotes the anticancer activity of sorafenib in hepatocellular carcinoma cells. |
Q91678604 | The activating transcription factor 2: an influencer of cancer progression |
Q55015657 | miR-144-5p Enhances the Radiosensitivity of Non-Small-Cell Lung Cancer Cells via Targeting ATF2. |
Search more.